News

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
Another type of stem cell transplant a doctor may consider is a peripheral blood stem cell transplant ... otherwise healthy people with Hodgkin’s lymphoma if initial treatments have been ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...
Blood cancers, encompassing leukaemia, lymphoma, and myeloma, arise from malfunctions in blood cell production and ... it’s crucial to get a peripheral blood smear and complete blood count ...
About 30 percent of all non-Hodgkin lymphoma ... a stem cell transplant immunotherapy treatment might be an option. First, doctors will remove stem cells from your bone marrow or blood.
Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...
In addition, analysis of patient blood samples at baseline and on ... of soquelitinib is enrolling patients with relapsed peripheral T cell lymphoma at multiple sites in the U.S., Canada and ...